Current role
Drug Manufacturers - General · Healthcare
Board Member
2025-07-01–present
Daniel Pinto
Board Member
Johnson & Johnson (JNJ)Equibles does not estimate personal net worth.
Get an email with a short summary when Johnson & Johnson publishes a filing, an earnings call transcript or a press release.
Get JNJ alertsAbout Daniel Pinto
Daniel Pinto is recorded as Board Member at Johnson & Johnson (JNJ) since July 1, 2025. Johnson & Johnson reported in an 8-K filed June 10, 2025 that Daniel Pinto was appointed Board of Directors, effective July 1, 2025. Johnson & Johnson is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Johnson & Johnson includes J. Wolk (CFO), D. E. Pinto (Board Member), Darius Adamczyk (Board Member) and 7 others.
“On June 10, 2025, Johnson & Johnson (the "Company" or "Johnson & Johnson") announced that Daniel Pinto was elected to the Board of Directors effective July 1, 2025.”
Affiliation history
-
Current
2025-07-01–present
Company network
Leadership on record at Johnson & Johnson
- J. Wolk CFO
- D. E. Pinto Board Member
- Darius Adamczyk Board Member
- Dr. Nadja West Board Member
- E. A. Woods Board Member
- Eugene A. Woods Board Member
- H. Joly Board Member
- J. A. Doudna Board Member
- J. Duato Board Member
- J. G. Morikis Board Member